Collegium Pharmaceutical, Inc.
COLL
$34.87
-$0.82-2.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 421.75M | 386.68M | 285.86M | 222.15M | 197.77M |
| Total Receivables | 228.76M | 211.33M | 233.95M | 213.02M | 228.71M |
| Inventory | 42.74M | 40.91M | 38.05M | 38.15M | 37.22M |
| Prepaid Expenses | 32.56M | 26.93M | 36.16M | 56.04M | 44.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 19.85M | 25.57M | 19.85M | 19.85M | 19.86M |
| Total Current Assets | 745.67M | 691.41M | 613.87M | 549.21M | 527.55M |
|
|
|||||
| Total Current Assets | 745.67M | 691.41M | 613.87M | 549.21M | 527.55M |
| Net Property, Plant & Equipment | 15.64M | 16.20M | 16.68M | 18.17M | 19.40M |
| Long-term Investments | 145.93M | 145.93M | 145.93M | 147.94M | 150.76M |
| Goodwill | 145.93M | 145.93M | 145.93M | 147.94M | 150.76M |
| Total Other Intangibles | 614.04M | 669.51M | 724.98M | 780.46M | 835.93M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 130.69M | 133.79M | 105.87M | 96.86M | 97.75M |
| Total Assets | 1.65B | 1.66B | 1.61B | 1.59B | 1.63B |
|
|
|||||
| Total Accounts Payable | 6.83M | 10.66M | 7.65M | 10.89M | 17.85M |
| Total Accrued Expenses | 210.24M | 227.32M | 217.93M | 229.08M | 230.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.07M | 30.41M | 65.96M | 65.92M | 65.89M |
| Total Finance Division Other Current Liabilities | 183.83M | 171.64M | 161.40M | 158.72M | 172.58M |
| Total Other Current Liabilities | 183.83M | 171.64M | 161.40M | 158.72M | 172.58M |
| Total Current Liabilities | 434.97M | 440.03M | 452.93M | 464.61M | 486.71M |
|
|
|||||
| Total Current Liabilities | 434.97M | 440.03M | 452.93M | 464.61M | 486.71M |
| Long-Term Debt | 891.83M | 901.89M | 865.81M | 880.96M | 894.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.79M | 4.13M | 4.50M | 4.85M | 5.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.94M | 9.11M | 9.28M | 10.00M | 10.40M |
| Total Liabilities | 1.34B | 1.36B | 1.33B | 1.36B | 1.40B |
|
|
|||||
| Common Stock & APIC | 621.78M | 625.00M | 615.12M | 598.98M | 593.28M |
| Retained Earnings | -86.63M | -101.13M | -118.09M | -149.60M | -161.58M |
| Treasury Stock & Other | -222.73M | -222.19M | -222.22M | -217.17M | -197.26M |
| Total Common Equity | 312.42M | 301.68M | 274.81M | 232.21M | 234.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 312.42M | 301.68M | 274.81M | 232.21M | 234.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 312.42M | 301.68M | 274.81M | 232.21M | 234.43M |
|
|
|||||